Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Elekta Provides VMAT and Radiosurgery Solutions for New Jersey Health System

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

UK Medical Device Testing Jumps 17%,...

Clinical investigations of medical devices in the UK reached...

Medtronic Secures FDA PMA for Infuse...

Medtronic announced that it has secured FDA premarket approval...

Medica Axon Diagnostics Merger Expands UK...

Teleradiology provider Medica Group has agreed to integrate Axon...

CentraState Medical Center , a part of the CentraState Healthcare System, currently is treating 45 to 50 patients a day – with fluctuations as high as 70 patients per day, all on one treatment unit. When the time came to add another treatment system, CentraState elected to replace another manufacturer’s system and install two new Elekta systems.

Jan Dragotta, Clinical Director, Radiation Oncology, says the decision process took several months and involved a team of CentraState physicians, physicists and administrators.

Robert Smith, MS, Director of Physics, says, Elekta’s reputation has grown in recent years, so we spent a lot of time comparing Elekta with other systems, and discovered that Elekta systems had many advantages over the competition, especially in imaging capabilities. We decided to make the switch to Elekta.

We’ll be replacing our current IMRT techniques with VMAT,” he explains. “We’re looking to VMAT to increase throughput, but more importantly to reduce treatment times for our patients. That, in turn, will reduce the chance of patient movement during the treatment, another big concern, especially in lung and abdomen applications. We feel we can deliver a better, more precise treatment to the patient by delivering the dose in a shorter time.

Edward Soffen, M.D., Medical Director, says, “VMAT is the newest, latest, greatest technology for conforming the beam as closely as possible to the target. Although we’re doing a good job now sparing healthy tissue, we’re taking it to the next level of sophistication with VMAT. It’s really advanced technology that will force others to be competitive with us, in terms of providing the most sophisticated technology available. We wanted the latest tools that really hone in on the tumor, give us better image guidance, and are compatible with our other hardware and software.”

Latest stories

Related stories

UK Medical Device Testing Jumps 17%, AI and Neurotech Lead

Clinical investigations of medical devices in the UK reached...

Medtronic Secures FDA PMA for Infuse Bone Graft in TLIF

Medtronic announced that it has secured FDA premarket approval...

Medica Axon Diagnostics Merger Expands UK Clinical Reporting

Teleradiology provider Medica Group has agreed to integrate Axon...

Sutter Health Integrates AI Decision Support in Epic EHR

Sutter Health is integrating artificial intelligence-powered decision support technology...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »